16 results
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
18 Dec 23
Third party tender offer statement (amended)
6:59am
toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
4 Dec 23
Third party tender offer statement (amended)
7:04am
toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
17 Nov 23
Third party tender offer statement (amended)
6:53am
toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials
SC TO-T/A
EX-99
LLY
Lilly(Eli) & Co
15 Nov 23
Third party tender offer statement (amended)
6:51am
. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
8 Nov 23
Third party tender offer statement (amended)
5:06pm
, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect
SC14D9C
EX-99.1
xx726mwqii h9fj0kqa
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC TO-C
EX-99.1
udc28tgefvigr1g 6xz
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-99.4
ff7mkbbvgyqq9i2ly i8
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-99.4
6j7b ts4uk
3 Oct 23
Tender and Support Agreement
7:35am
ARS
abau1t35 4qoa3mzjp
1 May 23
Annual report to shareholders
1:52pm
8-K
EX-99.1
3uu6xi3m 1c
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
424B3
sf34p
5 Aug 21
Prospectus supplement
4:26pm
S-4
j9vd7raa
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
425
EX-99.1
bk3zs
15 Mar 21
Business combination disclosure
8:20am
8-K
EX-99.1
i3bxrp
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
- Prev
- 1
- Next